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ABSTRACT
To meet the growing demand for synthetic
genes more robust, scalable and inexpensive
gene assembly technologies must be developed.
Here, we present a protocol for high-
quality gene assembly directly from low-cost
marginal-quality microarray-synthesized oligo-
nucleotides. Significantly, we eliminated the time-
and money-consuming oligonucleotide purification
steps through the use of hybridization-based selec-
tionembeddedintheassemblyprocess.Theprotocol
wastestedonmixturesofupto2000oligonucleotides
eluted directly from microarrays obtained from three
different chip manufacturers. These mixtures con-
taining <5% perfect oligos, and were used directly
for assembly of 27 test genes of different sizes.
Gene quality was assessed by sequencing, and their
activity was tested in coupled in vitro transcription/
translation reactions. Genes assembled from the
microarray-eluted material using the new protocol
matched the quality of the genes assembled from
>95% pure column-synthesized oligonucleotides by
the standard protocol. Both averaged only
2.7errors/kb, and genes assembled from
microarray-eluted material without clonal selection
produced only 30% less protein than sequence-
confirmed clones. This report represents the first
demonstration of cost-efficient gene assembly from
microarray-synthesized oligonucleotides. The
overall cost of assembly by this method approaches
5¢ per base, making gene synthesis more affordable
than traditional cloning.
INTRODUCTION
Synthetic gene production is a relatively new and fast
growing sector of the multi-billion dollar market of
biotechnological reagents. Fueled by the advances of
post-genomic technologies, the market has been doubling
annually for the past 5 years and is expected to grow at this
or higher rate for the next 5–10 years (1). Existing gene
assembly technologies use individually synthesized oligo-
nucleotides (oligos) as a starting material and require
clonal validation of the assembled products. These
methods will be unable to support the current pace of ex-
pansion of the synthetic gene market. Development of
more robust, easily scalable, time- and cost-efﬁcient gene
assembly technologies will be needed (2). Signiﬁcant
progress has already been made toward this goal.
Assembly of genes up to 2.5kb is now a routine process
that can take <2 weeks to complete. However, assembly of
large DNA molecules remains a challenge. Only a few syn-
thetic molecules over 10kb have been reported to date (3–
6), but those can be used for pasting together much larger
DNA fragments. Gibson et al. (7,8), for instance used them
for the assembly of Mycoplasma genitalium (580kb) and
M. mycoides (1.1Mb) genomes.
The major drawback of current gene assembly
technologies is the lack of internal quality control mech-
anisms. This leads to their dependency on the quality of
the starting oligos. To date, commercial gene assemblies
are performed using only the best available
column-synthesized oligos; however, even this does not
guarantee ﬂawless assembly. For instance, only one in
ten 1kb genes assembled from 50-mer oligos synthesized
with 99.9% coupling efﬁciency would be correct. The
other nine would carry sequences that were divergent
from the intended sequence. The number of mistakes
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making direct assembly of large molecules impractical.
More detailed evaluation of the current status of gene
assembly technologies can be found in recent reviews
(2,9–11).
Heterogeneity of assembly products is commonly ad-
dressed by the clonal selection, which includes cloning,
isolation, preparation and sequencing of a large number
of individual assemblies in order to identify those without
mistakes (12). This signiﬁcantly prolongs the gene produc-
tion process and contributes greatly to the cost of the ﬁnal
product. One way to increase frequency of ﬂawlessly
assembled products is to minimize the number of faulty
oligos available for the assembly. To some degree, this can
be achieved by the additional puriﬁcation of synthetic
oligos prior to their use. Chromatographic puriﬁcation is
an option available from most oligo vendors, but the
process is expensive and the separation is incomplete.
Much more efﬁcient separation can be achieved by poly-
acrylamide gel puriﬁcation, but this option is even more
expensive and is not available from all vendors. This
option was used by the Craig Venter Institute for
assembly of the ﬁrst synthetic genomes (4,7,8). To
reduce the oligo puriﬁcation cost, a uniform length oligo
design was used to enable bulk puriﬁcation of synthesized
oligos. Although still expensive, the approach was shown
to be very effective. When used to assemble a 5.4kb
f 174 genome,  10% of the generated molecules were
found to be infectious. Sequence analysis of several infec-
tious clones revealed the presence of  5 single nucleotide
substitutions per genome, most likely generated by DNA
polymerase (4).
The success of this oligo puriﬁcation scheme suggests
that the majority of mutations observed in synthetic
gene products are caused by the incorporation of poorly
synthesized oligos into the assemblies. Once prevented, it
led to dramatic improvement in the resulting gene quality.
Tian et al. (13) showed that a similar effect could be
achieved by a hybridization-based oligo puriﬁcation
process, but the high cost and complexity of the developed
protocol complicated its commercial adaptation.
However, a hybridization-based selection can be
employed not as a separate step, but integrated into the
gene assembly process. To enable such integration some
modiﬁcations of the assembly process would be required.
These would include: (i) a special oligo design enabling
normalization of the thermodynamic parameters of the
oligo pairings; and (ii) a way to maintain these parameters
unchanged throughout the assembly process to ensure its
efﬁciency. This can be accomplished by the implementa-
tion of a Tm-normalized oligo design and by avoidance of
polymerization-based steps that would alter Tm of these
oligos by their extension. Under the name of ligase chain
reaction (LCR), such a process was introduced over
10 years ago (14), but remained largely unnoted for
 5 years until it was successfully used for the assembly
of a 714bp green ﬂuorescence protein (GFP) gene
from Tm-normalized microarray-synthesized oligos (15).
The gene assembled by LCR directly from unampliﬁed
and unpuriﬁed low-quality oligos contained only
1–6errors/kb in contrast to 15–60errors/kb in the same
gene assembled from similarly designed and synthesized
oligos by a PCR-based method (16). The LCR-based
assembly demonstrated the power of hybridization-based
selection, but failed to address the low-yield issue unavoid-
ably associated with the use of microarray-synthesized
oligos. This drawback limited its use to low complexity,
high redundancy oligo pools.
The need to use column-synthesized oligos has become
the key factor limiting throughput and cost reduction po-
tentials for commercial gene production. The cost of these
oligos has remained constant for the past 4 years and any
future reduction is unlikely (11). Despite advancements in
modern column (or resin)-based oligo synthesizers, which
can now produce over 1500 oligos in a single run, these
machines are no match to the hundreds of thousands of
oligos inexpensively synthesized on a single microarray
chip (see (2) for review). Today a number of companies
offer custom microarray synthesis using variety of tech-
nical platforms, but only three vendors will elute the oligos
from the glass surface. These are LC Sciences, which
adopted the microﬂuidic technology developed by Zhou
et al. (15); Combimatrix, which uses the electrochemical
platform developed by Egeland and Southern (17); and
Agilent Technologies, which uses the inkjet technology
pioneered by Lasky and Hood (18).
In addition to the poor product quality and high pool
complexity, the use of microarray-synthesized oligos for
gene assembly presents an additional challenge. Yields of
microarray-synthesized oligos are six orders of magnitude
lower than those of column-synthesized ones and are not
nearly enough to accommodate assembly of all genes
designed in the pools without their prior ampliﬁcation.
Tian et al. were ﬁrst to overcome these problems by de-
veloping protocols for parallel ampliﬁcation and puriﬁca-
tion of complex oligo mixtures. Using these protocols,
they were able to assemble all 21 genes of the E. coli 30S
ribosomal subunit cluster from a single pool of
microarray-synthesized oligos (13). The quality of the
genes assembled by their protocol was 2- to 3-fold
higher than those built from microarray oligos that had
been puriﬁed by polyacrylamide gel electrophoresis, and
 10-fold higher than those assembled without
puriﬁcation.
Although other examples of successful gene assembly
from microarray-synthesized oligos exist (13,15,16,19) the
broad adoption of the protocols is tempered by their added
cost and technical complexity. The goal of this study was
not to add to the list of examples, but to develop a less
expensive and less complex alternative that would make
microarray-synthesized oligos feasible for commercial
gene production.
MATERIALS AND METHODS
Oligonucleotides
All Tm-normalized oligos were designed by the oligo
design algorithm described here with Tm 55±1  C
calculated by the Meinkoth and Wahl formula (20)
adjusted for a typical ligase/polymerase buffer
(Tm=61+0.41 (%G+%C)  675/n). All column-made
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microarray-synthesized oligos were ordered from LC
Sciences, Agilent Technologies or Combimatrix.
All microarray-synthesized oligos in the amount
 10pmol/pool were desalted on Biospin P6 mini-columns
(BioRad) by the protocol recommended by the manufac-
turer. The desalted mixture was divided into two equal
 5pM aliquots. One was stored at  80 C as a backup,
and another used for block assembly. The aliquots of
50 phosphorylated oligos from Invitrogen and LC
Sciences were used without any pre-treatment. The
aliquots of oligos from Agilent Technologies were
50 phosphorylated in 100mlo f1   OptiKinase buffer
supplemented with 1mM ATP and 10m of OptiKinase
(USB) by 30min incubation at 37 C followed by 15min
incubation at 65 C for heat inactivation of the enzyme.
The aliquots of 30 phosphorylated oligos from
Combimatrix were simultaneously 30 dephosphorylated
and 50 phosphorylated in 100mlo f1   T4 polynucleotide
kinase buffer supplemented with 1mM ATP and 10m of T4
polynucleotide kinase (NEB) by 30min incubation at
37 C followed by 15min incubation at 65 C for heat
inactivation of the enzyme. The generated pools of
50 phosphorylated oligos were precipitated by adjusting
the total volume to 100ml and adding 1ml of glycogen
(20mg/ml), 10ml of 3M Na-acetate, pH 5.2, and 200mlo f
acetone. The mixtures were incubated at  80 C for at least
an hour, and then centrifuged at 16000g for 10min. The
supernatants were discarded and the pellets washed several
times with 70% ethanol, dried and re-dissolved in 5mlo f
water.
Block assembly and ampliﬁcation
The 5ml aliquots of the acetone-precipitated oligos were
mixed with 5mlo f2   Taq DNA ligase buffer supple-
mented with 40% PEG6000 and 20m of Taq DNA ligase
(NEB). The mixture was heated to 95 C, incubated for
2min, then slowly cooled (30min) down to 58 C and
incubated at this temperature for 12h. Then 90mlo f
1.1  iProof buffer supplemented with 1mM dNTP and
2m iProof HF DNA polymerase (BioRad) was added
directly to the ligation reaction and the resulting mixture
was subjected to 10 cycles of polymerase cycling assembly
(PCA, also known as recursive PCR), with incubations at
98 C for 10s, 58‘C for 30s and 72 C for 15s. Next, the
PCA products were used for block ampliﬁcation. The re-
actions were performed in 30mlo f1  iProof buffer sup-
plemented with 1mM dNTP, 500nM of block-speciﬁc
primer, 0.6m iProof HF DNA polymerase and a 1ml
PCA aliquot used as a template. A and H blocks were
ampliﬁed independently by 35 cycles of incubations at
98 C for 10s, 58 C for 30s, 72 C for 15s. A blocks
were generated with the A-speciﬁc primer (50-GCAGCG
TCTGGAGTCTCCTC-30) and H blocks with the
H-speciﬁc primer (50-AGCAGCTCTCAGAGTCTT
TTC-30). The ampliﬁed A and H blocks were agarose gel
puriﬁed (Qiagen), quantiﬁed and mixed together at a 1:1
ratio. The resulting block mixture (600ng) was digested in
50mlo f1   NEBuffer 4 with 10m MlyI (NEB) at 37 C for
3h and puriﬁed from the cleaved ﬂanking regions by a
DNA puriﬁcation kit (Qiagen).
Assembly of the gene ampliﬁcation template and
individual gene ampliﬁcation
The mixture of ﬂank-trimmed blocks was assembled into a
gene ampliﬁcation template by an overlapping PCR. The
reaction was set in 30mlo f1   iProof buffer with 1mM
dNTP, 2.5ng of MlyI digested blocks and 0.6m iProof HF
DNA polymerase, and performed by 8 cycles of incuba-
tions at 98 C for 15s, 55 C for 28min, 72 C for 1min.
The resulting gene template was used for individual amp-
liﬁcation of each of the genes designed in the pool. The
individual reactions were set up in 50mlo f1   iProof
buffer supplemented with 500nM of gene-speciﬁc
primers, 1m iProof HF DNA polymerase and 1ml
aliquots of the generated gene template. Genes were
ampliﬁed by 35 cycles of 98 C for 10s, 55 C for 30s,
72 C and the ampliﬁed products were either used
directly or cloned into pCR-Blunt II-TOPO (Invitrogen)
vector for further evaluation.
In vitro translation and protein detection
Linear expression elements (LEEs) for expression in
coupled in vitro transcription/translation (IVT) system
(Invitrogen) were assembled by extension of the gene
assembly products with T7 promoter and terminator
regions taken from pEXP5 vector (Invitrogen) by
overlapping PCR (21). One micrograms of the PCR-
puriﬁed LEE was expressed in a 50ml IVT reaction
supplemented with 1mlo fS
35 labeled methionine
(PerkinElmer) and assembled according the manufactur-
er’s recommendation. The reaction was performed for 4h
at 37 C with continuous agitation. Five microlitres of the
IVT reaction was loaded per well on a pre-cast 4–12%
polyacrylamide gradient gel (BioRad), electrophoretically
separated and autoradiographed.
Special precautions
The high sensitivity of the developed protocols requires
extra attention to potential contamination and cross con-
tamination of samples when working with microarray-
synthesized oligos. Setup of the PCR workstations
should be in compliance with the forensic science good
laboratory practice (GLP) (22) and only barrier tips that
prevent DNA cross contamination should be used (www
.mbpinc.com/html/pdf/techreport/TechReport_313.pdf).
RESULTS AND DISCUSSION
The synthetic gene assembly approach presented here is an
adaptation of previously developed techniques that enable
high-quality gene assembly from microarray-synthesized
oligos. We were able to combine the ideas of
hybridization-based oligo selection (13,15) and parallel
ampliﬁcation (13,19) into a single process that allows
simple and cost-efﬁcient production of unlimited
amounts of high-quality building materials directly from
unpuriﬁed pools of microarray-synthesized oligos. For
them to work together, we reversed the typical order in
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selection occurs ﬁrst and the template ampliﬁcation is
performed second (schematic shown in Figure 1). This
enabled the coupling of the oligo selection process with
the assembly of intermediate double-stranded units, which
we call blocks. Once assembled, blocks are co-ampliﬁed as
a single pool, which is then used as a template for
assembly of individual genes.
To enable gene assembly from the pools of ampliﬁed
blocks, adjoining blocks were designed with short unique
regions of overlap, which thereby deﬁned their relative
positions and orientations. Due to these overlapping
regions, parallel ampliﬁcation of all intended blocks in
a single reaction is not possible, as ampliﬁcation would
result in the production of unconnected, internally
primed, partial blocks. To avoid this complication,
adjacent blocks are designed with alternatively distinct
ﬂanking sequences. We numbered the blocks as odd and
even based on their ﬂanking sequence, and ampliﬁed them
in separate reactions with appropriate pairs of block
ampliﬁcation primers.
Tm-normalized oligo design and gene recoding
Tm-normalized oligos were designed by an algorithm de-
veloped in-house and based on the Meinkoth and Wahl
formula adjusted for a typical ligase/polymerase buffer
(Tm=61+0.41 (%G+%C) 675/n) (20). Oligo de-
sign can be performed on individual genes or on a set of
genes concatenated into a virtual sequence to simplify uni-
formed block design. The algorithm tracks the sequence
along its length and breaks it into a set of adjoining frag-
ments having identical Tm values. In the experiments
described here the Tm value was set at 55±1 C. The
identiﬁed fragments served as halves of the predicted
oligos. Oligos for the upper strand were designed by
combining sequences of the Tm-normalized fragments 1
with 2, 3 with 4, 5 with 6, etc., and designed for the
lower strand by combining the sequences complimentary
to the fragments 2 with 3, 4 with 5, 6 with 7, etc. Together
they represented a thermodynamically uniformed set of
gene assembling oligos (GAOs).
Although this algorithm is suitable for designing
Tm-normalized oligos for any type of DNA molecule, we
took advantage of the fact that to date protein-encoding
sequences are in the highest demand. This enabled us to
use the redundancy of the amino acid translation table to
improve the accuracy and robustness of the assembling
process by disrupting GC- and AT-rich islands, direct
and inverted repeats, microsatellites and other undesirable
DNA features. Using the codon frequency database,
maintained by Kazusa DNA Research Institute, we
identiﬁed a set of 12 codons rarely used by either the
E. coli or mammalian translation machineries. To
evaluate the accuracy of our selection, we took six rarely
used by mammalian codons and used those to generate
‘choke’ points in a ﬁreﬂy luciferase gene (LUC) optimized
for mammalian expression. This commercially available
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Figure 1. Block-based gene assembly. (A) Schematics of the process. Design: All genes in the set are combined into a virtual string and the resulting
sequence is Tm-normalized. For simplicity, a set of four color-coded genes is shown. Oligos: Tm-normalized oligos are designed, synthesized and
pooled into a single mixture. Blocks: a pool of oligos is converted into a mixture of partially overlapping blocks of uniform size. Blocks are
assembled under tightly controlled, highly stringent conditions that prevent incorporation of improperly synthesized oligos. Assembled blocks are
ampliﬁed to generate sufﬁcient amount of material for the ampliﬁcation of all individual genes designed to be built from the oligo pool. Genes: the
ampliﬁed blocks are trimmed of their ﬂanking regions and combined into a single sequence by several rounds of overlapping PCR. The assembled
sequence is used as a template for ampliﬁcation of all genes in the set, each with its own set of gene-speciﬁc primers. (B) Detailed diagram of block
structure. Blocks are composed of unique gene-speciﬁc regions (GSR) built from GAOs and common ﬂanking regions (UPR), which enables their
co-ampliﬁcation. UPRs carry MlyI recognition sites, which are used for UPR cleavage. Two distinct UPR sequences are used in alternation from
block to block. Adjacent blocks share regions of overlap (BOR) enabling their covalent joining by overlapping PCR.
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most frequent mammalian codons (Max LUC). The
‘choke’ variants were generated from Max LUC by
swapping the  500bp region between unique BstBI and
EcoRV restriction sites with modiﬁed 500bp fragments.
Ala, Arg, Leu, Pro, Ser and Thr variants were generated
by replacing the corresponding codons in the region with
their rare alternatives: GCG, CGT, CTA, CCG, TCG or
ACG, respectively. Evaluation of luciferase activity in
murine cells transfected with these variants revealed that
replacement of Leu, Ser or Thr codons caused a statistic-
ally signiﬁcant  4-fold reduction in gene expression,
whereas replacement of Ala, Arg, Pro codons had only
marginal effects (Supplementary Figure S1). Based on
this evaluation, three of the above codons (GCG for
Ala, CGT for Arg and CCG for Pro) were removed
from the original list, leaving the ﬁnal list of codons to
be avoided for an efﬁcient gene expression in E. coli and
mammalian systems with nine codons: four for Arg
(AGG, AGA, CGG and CGA), two for Leu (TTA and
CTA), and one for each of Ile (ATA), Ser (TCG) and Thr
(ACG). These were excluded from usage to ensure
adequate expression of the recoded genes in either
system. All the remaining synonymous codons were used
interchangeably to modify gene sequences as desired to
facilitate assembly, without altering the amino acids of
the encoded proteins.
Gene recoding was completed by performing several
re-iterative rounds of intermediate recoding using
an in-house program followed by output analysis.
During the ﬁrst round, the program replaced all codons
speciﬁed as rare with randomly selected synonymous
codons. In the second, it removed restriction sites for the
list of enzyme speciﬁed by the operator. In the third, it
disrupted homopolymeric regions longer than 3nt and
repeat units over 6nt. And ﬁnally, the sequence was
normalized for purine/pyrimidine content within a
21-bp-long sliding window. The resulting sequence was
checked for all speciﬁed criteria; if any of them was not
met, the sequence was sent back for another recoding
attempt. If criteria were met, the sequence was fed into
the oligo design program and the predicted oligo set was
checked for unique pairings. If uniqueness was not con-
ﬁrmed, then the sequence was sent for recoding once
again. Each of the output sequences carried E. coli and
mammalian codon adaptation indexes (CAIs) (24) above
0.8, sufﬁcient for efﬁcient protein expression in either
system (25). The source codes of the developed recoding
and oligo design programs are provided in Supplementary
Material. Online versions of are available at http://www
.innovationsinmedicine.org/software/Tm-normalized-
oligo-design/.
We tested our recoding algorithm on the Plasmodium
falciparum merozoite surface protein (MSP) gene, which
is known to be poorly expressed in murine cells (26). In
addition to the wild type (WT) gene (mammalian CAI
0.25), two recoded versions were constructed. One by
recoding the gene using a conventional codon optimiza-
tion protocol (OPT) and another using the sequence nor-
malization algorithm described here (NRM). The
calculated mammalian CAI’s of OPT and NRM
variants were 0.99 and 0.85, respectively. The relative
gene activities of the three constructed versions were
assessed by (i) determination of MSP produced in trans-
fected NIH 3T3 cell cultures by immunoblot and (ii)
measurement of antigen-speciﬁc titers in sera of
immunized mice by ELISA. The WT gene produced no
detectable protein in transfected murine cells and
stimulated very low antibody titers in mice. In contrast,
both recoded versions expressed similarly robust levels of
protein in cell culture and stimulated similarly strong
immune responses in mice (Figure 2). Based on this
study, we concluded that robust gene expression can be
achieved without maximizing high-frequency codon
usage. We were able to achieve comparable improve-
ments in protein expression by avoiding only a small
number of rare codons.
Enzyme and oligo pool size selections
Since microarray-synthesis provides only femtomolar
amounts of oligos, the ability to use them without ampli-
ﬁcation relies on the substrate sensitivity of the enzyme
used. Five commercial enzymes [Taq DNA polymerase
(Promega), iProof (Bio-Rad), Pfu Ultra II (Stratagene),
HiFi (Roche) and Pf 50 (Invitrogen)] were tested for
their ability to utilize oligo substrates at sub-nanomole
concentrations. Taq DNA polymerase showed the
highest robustness and speciﬁcity, followed by iProof,
Pfu Ultra II and HiFi. Pf 50 failed to produce any
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Figure 2. Effect of sequence normalization on gene expression. Activity
of the native (WT) and two recoded versions of the malaria MSP gene
(NRM and OPT, see text for details) were compared by the levels of
their expression in NIH 3T3 cell cultures (A) and by the strength of the
immune respond in genetically immunized mice (B). (A) Nearly conﬂu-
ent NIH 3T3 cell cultures were transfected with the test constructs
using lipofectamine 2000 (Invitrogen) according to the manufacturer’s
protocol. After transfection, cells were incubated for 12h at 37 Ci na
CO2 incubator, and then harvested and lysed. The SDS soluble frac-
tions were analyzed by immunoblot using in-house generated a MSP
mouse sera (1:1000) and goat HRP-conjugated anti-mouse IgG+IgM
(H+L) (1:10000) purchased from KPL. Lane M: MagicMark XP
chemiluminescent molecular weight marker (Invitrogen); Lanes 1–3:
lysate of cells transfected with OPT, NRM, and WT MSP variants,
respectively. (B) Three groups (6 mice/group) of 2-month old BALB/
c mice were genetically immunized with a plasmid expressing one of the
MSP versions (12mg) delivered into the ear pinna at Weeks 0, 2 and 4.
Two weeks after the last immunization, the animals were bled and the
sera assayed for MSP antigen reactivity by ELISA using MSP-coated
plates and goat HRP-conjugated anti-mouse IgG+IgM (H+L)
(10000) purchased from KPL. Individual mouse titers are plotted on
a log scale as dots and group averages are represented by lines. 1: MSP
OPT; 2: MSP NRM; and 3: MSP WT-immunized mice.
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substrate tested (100pM) (Supplementary Figure S2).
Despite the robustness of Taq DNA polymerase, we
selected iProof for use in the subsequent experiments,
since it was the only high-ﬁdelity enzyme capable of
utilizing substrate at picomole concentrations.
Selection of the enzyme for the ligation step was limited
to Taq ligase, the only commercially available thermo-
stable DNA ligase, which unfortunately is highly sensitive
to substrate concentration (27). However, by supplement-
ing the reaction with 20% PEG6000 and increasing its
duration to over 6h, we were able to use it with
nanomole concentrations of oligos (Supplementary
Figures S3 and S4).
To deﬁne the limits of oligo pool complexity for suc-
cessful gene assembly, we selected ﬁve test genes of
220, 270, 320, 370 and 420bp, comprised of 8, 10, 12,
14 or 16 GAOs, respectively. Six pools with complexities
increasing from 250 to 8000 oligos were made by mixing
column-synthesized GAOs designed for these test genes
with those corresponding to other, irrelevant genes.
Using a standard gene building protocol (28), all ﬁve
test genes were successfully assembled from the pools
comprised of 1000 or fewer oligos. The two smaller
genes were assembled from the pool of 2000 oligos and
the smallest gene was generated from the pools of
4000 and 8000 oligos. However, the 8000-complex pool
also gave rise to the formation of unintended products,
suggesting loss of pairing speciﬁcity at this level of pool
complexity (Figure 3). Based on these results, we
concluded that to ensure the accuracy and robust-
ness of gene assembly pool complexities should be
limited to 4000 oligos, and the block sizes limited to
 270bp.
Block structure
The amount of material synthesized on a microarray chip
is not adequate for the assembly of all genes designed on
it. Ampliﬁcation of this material at some point is unavoid-
able, and for the reasons discussed below we choose to do
it on the block rather than on the oligo level. A structural
diagram of the block-based gene assembly process and
detailed block structure are shown in Figure 1. Each
block is comprised of a unique core built of GAOs and
common ﬂanking regions enabling co-ampliﬁcation of
blocks sharing common ﬂanking sequences. To enable
removal of these regions after block ampliﬁcation, they
contained embedded recognition sites for a Type IIS
restriction enzyme (MlyI) that accommodated their
cleavage. The adjacent blocks were designed with short
areas of overlap so that they could be combined into
longer fragments by overlapping PCR (29) or some
other covalent DNA attachment method. To enable
parallel assembly and ampliﬁcation of the entire plurality
of blocks from a single oligo pool, adjoining blocks were
designed with alternating ﬂanking sequences. By
alternating these common end sequences, the number of
different block-ﬂank categories was limited to two. Use of
different ﬂanking regions on adjacent blocks is essential
for ampliﬁcation of all blocks from a single oligo mixture.
Without alternation of common ﬂanks, an attempt to
co-amplify two adjacent blocks would result in a partial
block ampliﬁcation of only their overlapping regions.
To evaluate the effect of ﬂanking sequences on the spe-
ciﬁcity and robustness of block ampliﬁcation and efﬁ-
ciency of MlyI cleavage, we compared the performance
of 12 randomly designed ﬂanking sequences and did not
ﬁnd any signiﬁcant differences between them by these
criteria (Supplementary Table S1). However, for the
purpose of consistency all experiments in this study were
performed using adapter sequences GCAGCGTCTGGA
GTCTCCTC and AGCAGCTCTCAGAGTCTTTTC
designated as A and H, respectively.
Block assembly and ampliﬁcation
The initial DNA ligase step of block assembly requires
oligos with 50 phosphate and 30 hydroxyl groups.
Depending on the vendor, oligos were delivered in one
of three formats: 50-P/30-OH, 50-OH/30-OH or 50-OH/
30-P. Oligo mixtures in the 50-P/30-OH format were used
without modiﬁcations; those delivered in the 50-OH/30-OH
format were 50 phosphorylated with OptiKinase; and
ABC D EF
1 23456
810 1214 16 810 1214 16 810 1214 16 810 1214 16 810 1214 16 810 1214 16
1 23456 1 23456 1 23456 1 23456 1 23456
250 500 1000 2000 4000 8000
Figure 3. Effect of oligo pool complexity on the robustness of gene assembly. Five sets of GAOs designed for the assembling of ﬁve different test
genes comprised of 8, 10, 12, 14 or 16 oligos were mixed with increasing numbers of irrelevant but similarly designed GAOs to create oligo pools
with 250, 500, 1000, 2000, 4000 and 8000 complexities. The pools were diluted to 1nM/oligo and used for assembling the test genes by 10 cycles of
PCA followed by 35 cycles of a standard PCR as described in ‘Materials and Methods’ section. The expected 220, 270, 320, 370 and 420bp products
were separated by agarose gel electrophoresis and visualized by ethidium bromide staining. Products assembled from the 250, 500, 1000, 2000, 4000
and 8000 GAO complex pools are presented in (A), (B), (C), (D), (E) and (F), respectively. Lane 1—100bp DNA ladder (NEB); lane 2—gene 1
(220bp); line 3—gene 2 (270bp); lane 4—gene 3 (320bp); lane 5—gene 4 (370bp); and lane 6—gene 5 (420bp).
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dephosphorylated and 50 phosphorylated with T4 poly-
nucleotide kinase. Once the ends of the oligos were
properly modiﬁed they were used in the DNA
ligase-driven assembling reaction coupled with a highly
stringent oligo selection process. We calculated that at
the concentrations that are achievable with microarray-
synthesized oligos proper pairing in 1 Taq DNA ligase
buffer would take over 140h (Supplementary Material).
This rendered LCR, with its constantly interrupted short
annealing steps, impractical and argued in favor of a
reaction performed at a constant temperature that would
not disrupt the oligo pairings. To shorten the reaction,
time ligation buffer was supplemented with PEG6000.
This resulted in 20-fold acceleration of the oligo pairing
process, reducing the reaction time to 7h. The reaction
was performed at a temperature 3 C over the Tm of the
oligos since an analysis of single nucleotide mismatch as-
sociation kinetics (30) suggested that this temperature is
optimal for achieving maximal stringency of the oligo se-
lection process (Supplementary Figure S5). Our own data
showed that raising the reaction temperature from 55 Ct o
58 C did not have a noticeable effect on the product yield
(Supplementary Figure S6).
Next, the relatively short fragments generated by the
ligase reaction were extended by 10 cycles of PCA. This
step, although not essential, contributed signiﬁcantly to
the size of the fragments that could be assembled from
the generated template and to the robustness of block
ampliﬁcation (Supplementary Figure S7). The PCA-
generated mixture was split into two aliquots. One
aliquot was used for ampliﬁcation of the A-ﬂanked
blocks using the A-block speciﬁc primer, whereas the
other was used for ampliﬁcation of the H-ﬂanked blocks
using the H-block speciﬁc primer. Although parallel
unbiased ampliﬁcation of far more complex mixtures of
much larger DNA fragments has been shown earlier (31)
we performed our own evaluation. To test ampliﬁcation
bias, we followed 80 randomly selected blocks within a 252
block mixture generated from a 2000-complex oligo pool.
We found all 80 blocks equally represented in the
generated mixture (Supplementary Figure S8a). To
assess the possibility of using the generated block
mixture as a renewable source of the gene building
material, the block mixture was re-evaluated after two
rounds of re-ampliﬁcation. Seventy eight blocks were
still represented evenly in the mixture, but the presence
of the other two blocks was signiﬁcantly diminished
(Supplementary Figure S8b). This suggests that block
re-ampliﬁcation should be limited to 1–2 rounds to
avoid reduction of pool complexity.
Assembling blocks into a gene ampliﬁcation template
In preparation for their use in gene assembly, the
co-ampliﬁed blocks were treated with MlyI to remove
the ﬂanking regions and then assembled into long continu-
ous DNA fragments by several cycles of PCA. The result-
ing mixture was used as a template for ampliﬁcation of all
individual genes designed in the pool. Optimization of
PCA conditions was performed on the 252-complex
block mixture described above assembled from microarray
oligos synthesized by Agilent. Success of gene assembly by
35 cycles of a standard PCR was used as a criterion for
evaluating the quality of the generated template. We
found that block concentration, length of the annealing
step, and the number of cycles were the most critical par-
ameters deﬁning assembly of an optimal gene ampliﬁca-
tion template (Figure 4). The reaction should contain at
least 20fmol of each individual block. The quality of the
generated template gradually increased with extension of
the annealing time and was found to be highest at 28min.
Assembly of the template required only 6 cycles of amp-
liﬁcation. Additional cycling was not useful, and on the
contrary, appeared to reduce the quality of the generated
template.
1 23456789 1 0 1 1 1 2 23456789 1 0 1 1 1 2
B A
123456 78 123456
Figure 4. Optimizing assembly of blocks into template for gene production. (A) Evaluating effect of annealing time. A 252-element mixture of MlyI
cleaved blocks (20fmol/block) assembled from a 2000-complex pool of microarray-synthesized oligos, was subjected to ﬁve cycles of PCA with
increasing annealing times from 0 to 35min. To evaluate robustness of the PCA-generated template 1ml aliquots of the reactions were used for
ampliﬁcation of 2.1 and 1.3kb genes with pairs of gene-speciﬁc primers. The ampliﬁed products were separated by agarose gel electrophoresis and
visualized by ethidium bromide staining. Lanes 1–6—products ampliﬁed from the templates generated by the reactions that carried, respectively, 0, 2,
9, 18, 28 and 35-min long annealing steps; lane 7—100bp DNA ladder (NEB); and lane 8–1kb DNA ladder (NEB). (B) Evaluating effect of PCR
cycle number. The block mixture described in (A) was subjected to an increasing number of PCA cycles performed with a 25-min annealing step.
Robustness of the generated templates was evaluated as described in the (A). Lane 1—1kb DNA ladder (NEB); and lanes 2–12—products ampliﬁed
from the templates assembled using 0 to 10 PCA cycles, respectively.
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To evaluate efﬁciency of the introduced hybridization-
based oligo selection process and the quality of the result-
ing products, we cloned and sequenced genes generated by
this protocol from the pools of Tm-normalized microarray
oligos synthesized by three independent vendors
(LC Sciences, Agilent, Combimatrix) and from an identi-
cal mixture of the adequately diluted Tm-normalized
column-synthesized oligos (Invitrogen). The results of
this analysis and accumulated data on the quality of
products assembled by the standard protocol from
length-normalized (60-mer) column-made oligos
(Invitrogen, Sigma, Qiagen, Macrogenics) are summarized
in Table 1. All evaluated samples showed similar types and
frequencies of errors regardless of the source of the oligos
used for their assembly. We interpret these results as an
indication that the coupled selection/assembly process pre-
sented here is effective. Incorporation of an oligo into an
assembling molecule is no longer based on its availability
in the mixture, but rather on the homology of its sequence
to the target. This relaxes dependency of product quality
on the quality of the starting oligos, and enables high-
quality gene assembly directly from unpuriﬁed mixtures
of microarray-synthesized oligos. Regardless of the oligo
source the genes assembled by the protocol described here
contained 2.7–2.9 errors/kb, mostly represented by single-
nucleotide deletions, compared to 2.8 errors/kb observed
in the genes assembled from high-quality length-
normalized column-synthesized oligos by standard
protocols.
For 6 of the 27 genes assembled from one of the micro-
array oligo pools, we identiﬁed ﬂawless clonal equivalents.
These were used as reference standards for the evaluation
of translation activity of the gene assemblies used directly
without clonal selection. Each gene was assembled in
two forms: one directly from the PCR-generated product
of gene assembly, and another using the identiﬁed
clonal equivalent as a template. All were ﬂanked with
T7 promoter and terminator and expressed in a coupled
bacterial in vitro transcription/translation system
(Invitrogen). Each pair expressed similar levels of
polypeptide of the predicted molecular weight (Figure 5).
In a separate experiment performed similarly, but on a dif-
ferent set of genes, we estimated the quantites of the
generated polypeptides by measuring radioactivity of the
TCA-insoluble fractions (Supplementary Table S2). Genes
assembled directly from the PCR-generated templates
averaged polypeptide yields of 30% less than those
assembled from the sequence-conﬁrmed templates, consist-
ent with the observed error frequencies.
CONCLUSIONS
The protocol presented here eliminates the expensive
and technically challenging oligo puriﬁcation steps and
makes the use of microarray-synthesized oligos feasible,
offering a 100-fold material cost reduction. However,
microarray-synthesized oligos present other challenges
besides the low quality. They are available only in the
Table 1. Error types and frequencies in the genes assembled by the regular and the block-based protocols from the column- and
microarray-synthesized oligos
Protocol Oligos Type of mutations per kb Total
Design Source Insertions Deletions Substitutions
Regular
a Length normalized Various (>100Mb) 0.1 2.5 0.2 2.8
Block based
b Tm-normalized Invitrogen ( 100kb) 0.1 (13
c) 2.2 (227) 0.3 (25) 2.7 (265)
LC Sciences ( 100kb) 0.2 (17) 2.3 (232) 0.3 (32) 2.8 (281)
Agilent ( 50kb) 0.1 (3) 2.4 (117) 0.3 (14) 2.7 (134)
Combimatrix ( 10kb) 0.1 (1) 2.2 (22) 0.6 (6) 2.9 (29)
aRepresent a summary of data collected by authors over years from analysis of 600–800-bp-long assemblies representing entire proteomes of several
bacterial (Bacillus anthracis, Chlamydia pneumoniae) and viral (CPV, HSV) virus genomes built from 60-mer oligos synthesized by Invitrogen, Sigma
and Macrogenics by the most commonly used protocol (28).
bRepresent a summary of data collected during this study from the genes assembled by the described protocol from several independent
Tm-normalizedmicroarray oligo pools (three from LC Sciences, two from Agilent and one from Combimatrix) and one artiﬁcial pool of column-made
oligos (Invitrogen).
cNumbers in the parentheses represent the actual numbers of observed mutations.
75 kD
50 kD
37 kD
25 kD
20 kD
15 kD
12 34 56 78 9 1 0 1 1 1 2
Figure 5. In vitro expression of the synthetic genes. PCR-generated
gene assemblies and their cloned, sequence-conﬁrmed equivalents
were assembled into T7 promoter-driven expression cassettes and
expressed in a coupled in vitro transcription/translation system. The
35S–methionine labeled products were separated by polyacrylamide
gel electrophoresis and detected by autoradiography. All genes were
evaluated in pairs, although not all pairs were fractionated on the
same gel. The picture is a composite of gels normalized relative to a
common precision plus WesternC standard (Bio-Rad). Odd lanes—
products generated by the cassettes assembled from the sequence con-
ﬁrmed clones; even lanes—products generated by the cassettes
assembled directly from PCR-generated gene assemblies. Lanes 1 and
2—gene CA1; lanes 3 and 4—gene ENO1L1; lanes 5 and 6—gene
LIN7A; lanes 7 and 8—gene PY00523; lanes 9 and 10—gene
PY07543; and lanes 11 and 12—gene PY04421.
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too low for use with the standard protocols. To date,
several attempts have been made to adapt this source of
oligos for gene assembly (13,15,16,19), but complexity of
the protocols outweighed the practical beneﬁts.
Our protocol is free from any oligo ampliﬁcation or
puriﬁcation steps. Instead of physically removing poorly
made oligos from the mixture, we used a highly stringent
hybridization approach based on a Tm-normalized oligo
design that prevented their incorporation into the
assemblies. By avoiding the oligo ampliﬁcation step,
commonly used to increase the amount of gene building
material, but unavoidably converting them into a
double-stranded format, we were able to couple the
oligo selection and gene assembly into a single process.
The issue of the low amounts of microarray-synthesized
oligos was addressed latter in the process by
co-ampliﬁcation of uniformly sized DNA fragments,
rather than the oligos themselves. Block ampliﬁcation
had the added beneﬁt of reducing the risk of biased amp-
liﬁcation by reducing the complexity of the ampliﬁed
mixture 10-fold. Furthermore, the generated blocks can
be evaluated for perfection and used as a renewable
source of error-free gene assembly material (12).
The oligo design algorithm we developed is applicable
to all types of DNA sequences. However, when used to
design protein-encoding genes it can be combined with the
removal of rare codons, direct and inverted repeats,
homopolymeric regions, GC or AT islands and other
sequence abnormalities that may complicate the gene
assembly process or reduce its efﬁciency. This method of
recoding allows control of the speciﬁcity of oligo pairing
and reduces the length of the oligos that simpliﬁes their
synthesis and reduces their cost.
However, one feature of this protocol still needs atten-
tion. This is the risk of cross-contamination upon reuse of
the block ampliﬁcation primers. So far, we were able to
avoid it by strictly following GLP regulations similar to
those used in forensic labs. To eliminate this risk entirely,
we are currently modifying our oligo design program to
design a new set of ﬂanking regions for every newly
designed oligo pool. We have shown that the yields and
speciﬁcity of the block ampliﬁcation step is not limited to
a speciﬁc set of primers, suggesting an endless number of
sequences are possible for them.
The genes constructed from microarray-synthesized
oligos using our block-based gene assembly protocol
were found to be indistinguishable from genes assembled
by the standard protocol from the high-quality column-
synthesized oligos. Sampling oligo pools from three differ-
ent vendors, we demonstrated the robustness and
cost-efﬁciency of the new method. It allows parallel
assembly of several dozens of average size genes from a
single oligo mixture purchased for less than a thousand
dollars. Depending on the pool complexity, this reduces
the material cost to a range from 1.5¢ to 0.5¢per base and
the total cost of gene assembly to from 5¢ to 3¢/bp. The
entire process takes only a few days and is easily scalable.
Even without the implementation of robotics, a single
operator can produce several hundred genes per week.
The high ﬁdelity of the process makes the assembled
genes usable without cloning. If accepted by the
customer, the non-clonal gene format would contribute
signiﬁcantly to further cost reduction, and fast and
cost-efﬁcient production of large numbers of genes for a
wide variety of research programs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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